Prospective Evaluation of Two iStent ® Trabecular Stents, One iStent Supra ® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes

ConclusionIOP control was achieved safely with two trabecular micro-bypass stents, one suprachoroidal stent, and postoperative prostaglandin. This microinvasive, ab interno approach introduces a possible new treatment option for refractory disease.Trial RegistrationNCT01456390.FundingGlaukos Corporation.

http://link.springer.com/10.1007/s12325-018-0666-4

Source: Advances in Therapy - February 23, 2018 Category: Drugs & Pharmacology Source Type: research